<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03652207</url>
  </required_header>
  <id_info>
    <org_study_id>Beneo_OBU_101108Final</org_study_id>
    <nct_id>NCT03652207</nct_id>
  </id_info>
  <brief_title>Effects of Palatinose™ on Weight Management and Body Composition</brief_title>
  <official_title>The Effects of Palatinose™ on Weight Management and Body Composition in Overweight and Obese Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beneo-Institute</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beneo-Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess body weight and body composition changes in overweight and obese
      persons consuming an energy-reduced diet containing foods with either sucrose or isomaltulose
      (Palatinose(TM)) over a period of 3 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2009</start_date>
  <completion_date type="Actual">June 30, 2010</completion_date>
  <primary_completion_date type="Actual">June 30, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Weight Change</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body weight Change over a 12-week period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body fat percentage measured using the BodPod</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postprandial respiratory quotient (RQ)</measure>
    <time_frame>120 minutes postprandial</time_frame>
    <description>postprandial energy metabolism, i.e. respiratory quotient (RQ) and fat oxidation measured by indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>12 weeks</time_frame>
    <description>Body mass index (kg/m2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>12 weeks</time_frame>
    <description>Waist circumference assessed using a measuring tape</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Overweight and Obesity</condition>
  <condition>Diet Modification</condition>
  <condition>Body Weight</condition>
  <arm_group>
    <arm_group_label>Sucrose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Test products i.e. low-fat yogurt drink, fruits drink and sweetener sachet for cereals containing sucrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Palatinose(TM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test products i.e. low-fat yogurt drink, fruits drink and sweetener sachet for cereals containing isomaltulose (Palatinose™)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>isomaltulose (Palatinose(TM)</intervention_name>
    <description>isomaltulose containing food products, i.e. low-fat yogurt drink, fruits drink and sweetener sachet for cereals, consumed within an energy-reduced diet</description>
    <arm_group_label>Palatinose(TM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>sucrose containing food products, i.e. low-fat yogurt drink, fruits drink and sweetener sachet for cereals, consumed within an energy-reduced diet</description>
    <arm_group_label>Sucrose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is healthy at the time of pre-examination

          -  Subject has a BMI of 25 - 35 kg/m² and motivated to lose weight

          -  Subject is aged 18 - 60 years at the time of pre-examination

        Exclusion Criteria:

          -  Person suffers from an acute or chronic disease

          -  Person has known dietary restrictions or allergies to Foods

          -  Intake of medications which interfere with body composition, appetite, satiety or food
             intake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oxford Brookes University</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 0BP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Maresch CC, Petry SF, Theis S, Bosy-Westphal A, Linn T. Low Glycemic Index Prototype Isomaltulose-Update of Clinical Trials. Nutrients. 2017 Apr 13;9(4). pii: E381. doi: 10.3390/nu9040381. Review.</citation>
    <PMID>28406437</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 27, 2018</study_first_submitted>
  <study_first_submitted_qc>August 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>August 27, 2018</last_update_submitted>
  <last_update_submitted_qc>August 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

